← Eichor
Condition: Unresectable Gastrointestinal Stromal Tumor Gist Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Unresectable Gastrointestinal Stromal Tumor Gist

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
NA · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06507683A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Phase 3 · 126 location(s) · Cogent Biosciences, Inc. · NCT05208047Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05461664Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
Phase 1 · 2 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07618377A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05464875A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatini
Phase 3 · 124 location(s) · GlaxoSmithKline · NCT07218926
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.